Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice

Environmental Health Perspectives

Volumn 106, Issue SUPPL. 5, 1998, Pages 1131-1137

  Weinberg, J Brice ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Arthritis; Autoimmunity; Glomerulonephritis; Knockout; Macrophage; Monocyte; Nitric oxide; Peroxynitrite; Superoxide; Vasculitis

Indexed keywords

DNA ANTIBODY; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RHEUMATOID FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; AUTOIMMUNITY; CONFERENCE PAPER; GLOMERULONEPHRITIS; IMMUNE COMPLEX DEPOSITION; INFLAMMATION; MEDIATOR; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULITIS;

ANIMALIA; RODENTIA;

EID: 0031760780     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.98106s51131     Document Type: Conference Paper

References (92)

1. Cush JJ, Lipsky PE. Cellular basis for rheumatoid inflammation. Clin Orthop Relat Res 265:9-22 (1991).
2. Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 322:1277-1289 (1990).
3. Weyand CM, Goronzy JJ. Pathogenesis of rheumatoid arthritis. Adv Rheumatol 81:29-55 (1997).
4. Brennan FM, Feldmann M. Cytokines in autoimmunity. Curr Opin Immunol 4:754-759 (1992).
5. Alvaro-Gracia JM, Zvaifler NJ, Brown CB, Kaushansky K, Firestein GS. Cytokines in chronic inflammatory arthritis. VI:Analysis of the synovial cells involved in granulocytemacrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-alpha. J Immunol 146:3365-3371 (1991).
6. Talal N. Interleukins, interferon and rheumatic disease. Clin Rheum Dis 11:633-644 (1985).
7. Hooks JJ, Jordan GW, Cupps T, Moutsopoulos HM, Fauci AS, Notkins AL. Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis. Arthritis Rheum 25:396-400 (1982).
8. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012 (1993).
9. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064 (1992).
10. Beckman JS, Crow JP. Pathological implications of nitric oxide, Superoxide and peroxynitrite formation [Review]. Biochem Soc Trans 21:330-334 (1993).
11. Magrinat G, Mason SN, Shami PJ, Weinberg JB. Nitric oxide modulation of human leukemia cell differentiation and gene expression. Blood 80:1880-1884 (1992).
12. Punjabi CJ, Laskin DL, Heck DE, Laskin JD. Production of nitric oxide by murine bone marrow cells. Inverse correlation with cellular proliferation. J Immunol 149:2179 (1992).
13. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms [Review]. Science 258:1898-1902 (1992).
14. Nathan C, Xie Q-W. Regulation of biosynthesis of nitric oxide. J Biol Chem 269:13725-13728 (1994).
15. Palmer RM, Hickery MS, Charles IG, Moncada S, Bayliss MT. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun 193:398-405 (1993).
16. Charles IG, Palmer RMJ, Hickery MS, Bayliss MT, Chubb AP, Hall VS, Moss DW, Moncada S. Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proc Natl Acad Sci USA 90:11419-11423 (1993).
17. Stefanovic-Racic M, Stadler J, Georgescu HI, Evans CH. Nitric oxide synthesis and its regulation by rabbit synoviocytes. J Rheumatol 21:1892-1898 (1994).
18. Gross SS, Levi R. Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem 267:25722-25729 (1992).
19. Rosenkranz-Weiss P, Sessa WC, Milstien S, Kaufman S, Watson CA, Pober JA. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells: elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest 93:2236-2243 (1994).
20. Assreuy J, Cunha FQ, Liew FY, Moncada S. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol 108:833-837 (1993).
21. Rogers NE, Ignarro LJ. Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem Biophys Res Commun 189:242 (1992).
22. Denis M. Human monocytes/macrophages: NO or no NO? J Leukoc Biol 55:682-684 (1994).
23. Curran RD, Billiar TR, Stuehr DJ, Ochoa JB, Harbrecht BG, Flint SG, Simmons RL. Multiple cytokines are required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg 212:462-469 (1990).
24. Sherman PA, Laubach VE, Reep RB, Wood ER. Purification and cloning of a cytokine-induced nitric oxide synthase from a human rumor cell line. Biochemistry 32:11600-11605 (1993).
25. Geller DA, Lowenstein CJ, Shapiro RA, Nussler AK, Di Silvio M, Wang SC, Nakayama DK, Simmons RL, Snyder SH, Billiar TR. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes. Proc Natl Acad Sci USA 90:3491-3495 (1993).
26. Demaria N, Colantoni A, Fagiuoli S, Liu GJ, Rogers BK, Farinati F, Vanthiel DH, Floyd RA. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med 21:291-295 (1996).
27. Denis M. Tumor necrosis factor and granulocyte macrophagecolony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates. J Leukoc Biol 49:380-387 (1991).
28. Paul-Eugene N, Mossalayi D, Sarfati M, Yamaoka K, Aubry JP, Bonnefoy JY, Dugas B, Kolb JP. Evidence for a role of Fc epsilon RII/CD23 in the IL-4-induced nitric oxide production by normal human mononuclear phagocytes. Cell Immunol 163:314-318 (1995).
29. Weinberg JB, Misukonis MA, Shami PJ, Mason SN, Sauls DL, Dittman WA, Wood ER, Smith GK, McDonald B, Bachus KE, et al. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS). Analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 86:1184-1195 (1995).
30. Kobzik L, Bredt DS, Lowenstein CJ, Drazen J, Gaston B, Sugarbaker D, Stamler JS. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 9:371-377 (1993).
31. Tracey WR, Xue C, Klinghofer V, Barlow J, Pollock JS, Forstermann U, Johns RA. Immunochemical detection of inducible NO synthase in human lung. Am J Physiol 266:L722-727 (1994).
32. Nicholson S, Bonecinialmeida MDG, Silva LE Jr., Nathan C, Xie QW, Mumford R, Weidner JR, Calaycay J, Geng J, Boechat N, et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 183:2293-2302 (1996).
33. Hibbs JB Jr., Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski RL, Ward JH, Menlove RL, McMurry MP, Kushner JP, Samlowski WE. Evidence for cytokine-inducible nitric oxide synthesis from I-arginine in patients receiving incerleukin-2 therapy. [Published erratum appears in J Clin Invest 90(1):295 (1992)]. J Clin Invest 89:867-877 (1992).
34. Anstey NM, Weinberg JB, Hassanali M, Mwaikambo ED, Manyenga D, Misukonis MA, Arnelle DR, Hollis D, McDonald MI, Granger DL. Nitric oxide in Tanzanian children with malaria. Inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med 184:557-567 (1996).
35. St. Clair EW, Wilkinson WE, Lang T, Sanders L, Misukonis MA, Gilkeson GS, Pisetsky DS, Granger DL, Weinberg JB. Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients, J Exp Med 184:1173-1178 (1996).
36. Clancy RM, Abramson SB. Nitric oxide-a novel mediator of inflammation [Review]. Proc Soc Exp Biol Med 210:93-101 (1995).
37. Stadler J, Stefanovic-Racic M, Billiar TR, Curran RD, McIntyre LA, Georgescu HI, Simmons RL, Evans CH. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 147:3915-3920 (1991).
38. Evans CH, Stefanovic-Racic M, Lancaster JR Jr. Nitric oxide and its role in orthopaedic disease [Review], Clin Orthop Relat Res 312:275-294 (1995).
39. McInnes LB, Leung BP, Wei XQ, Huang F-P, Sturrock RD, Kinninmonth A, Weidner J, Mumford R, Liew FY. Field M, Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 184:1519-1524 (1996).
40. Clancy RM, Leszczynska-Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 90:1116-1121 (1992).
41. Darius H, Grodzinska L, Meyer J. The effects of the nitric oxide donors molsidomine and SIN-1 on human polymorphonuclear leucocyte function in vitro and ex vivo. Eur J Clin Pharmacol 43:629-633 (1992).
42. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651-4655 (1991).
43. Stamper JS, Loscalzo J. The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders [see Comments]. J Am Coll Cardiol 18:1529-1536 (1991).
44. Harris ED Jr. Textbook of Rheumatology. 4th ed. Philadelphia:W.B. Saunders 1993.
45. 2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol Chem Hoppe-Seyler 373:897-902 (1992).
46. Marotta P, Sautebin L, Di Rosa M. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774. Br J Pharmacol 107:640-641 (1992).
47. Imai Y, Kolb H, Burkart V. Nitric oxide production from macrophages is regulated by arachidonic acid metabolites. Biochem Biophys Res Commun 197:105-109 (1993).
48. Stadler J, Harbrecht BG, Di Silvio M, Curran RD, Jordan ML, Simmons RL, Billiar TR. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells. J Leukoc Biol 53:165-172 (1993).
49. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90:7240-7244 (1993).
50. Swierkosz TA, Mitchell JA, Warner TD, Botting RM, Vane JR. Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br J Pharmacol 114:1335-1342 (1995).
51. Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, Willoughby DA. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA 91:2046-2050 (1994).
52. Salvemini D, Manning PT, Zweifel BS, Seibert K, Connor J, Currie MG, Needleman P, Masferrer JL. Dual inhibition of ngitric oxide and prostaglandin production contributes to the anti-inflammatory properties of nitric oxide synthase inhibitors. J Clin Invest 96:301-308 (1995).
53. Amin AR, Vyas P, Attur M, Leszczynska-Piziak J, Patel IR, Weissmann G, Abramson SB. The mode of action of aspirinlike drugs: effect on inducible nitric oxide synthase. Proc Natl Acad Sci USA 92:7926-7930 (1995).
54. Stefanovic-Racic M, Stadler J, Evans CH. Nitric oxide and arthritis. Arthritis Rheum 36:1036-1044 (1993).
55. Tamir S, Derojaswalker T, Gal A, Weller AH, Li XT, Fox JG, Wogan GN, Tannenbaum SR. Nitric oxide production in relation to spontaneous B-cell lymphoma and myositis in SJL mice. Cancer Res 55:4391-4397 (1995).
56. Vodovotz Y, Geiser AG, Chesler L, Letterio J, Campbell A, Lucia MS, Sporn MB, Roberts AB, Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta-1 null mouse. J Exp Med 183:2337-2342 (1996).
57. Vodovotz Y, Bogdan C, Paik J, Xie QW, Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J Exp Med 178:605-613 (1993).
58. Farrell AJ, Blake DR, Palmer RM, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51:1219-1222 (1992).
59. Stichtenoth DO, Fauler J, Zeidler H, Frolich JC. Urinary nitrate excretion is increased in patients with rheumatoid arthritis and reduced by prednisolone. Ann Rheum Dis 54:820-824 (1995).
60. Grabowski PS, England AJ, Dykhuizen R, Copland M, Benjamin N, Reid DM, Ralston SH. Elevated nitric oxide production in rheumatoid arthritis-detection using the fasting urinary nitrate/creatinine ratio. Arthritis Rheum 39:643-647 (1996).
61. Kaur H, Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation-nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 350:9-12 (1994).
62. Sakurai H, Kohsaka H, Liu MF, Higashiyama H, Hirata Y, Kanno K, Saito I, Miyasaka N, Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 96:2357-2363 (1995).
63. Ueki Y, Miyake S, Tominaga Y, Eguchi K. Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 23:230-236 (1996).
64. Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Ann Rev Immunol 9:243-269 (1991).
65. Nagata S, Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol Today 16:39-43 (1995).
66. G-monomethyl-L-arginine. J Exp Med 179:651-660 (1994).
67. Dang-Vu AP, Pisetsky DS, Weinberg JB. Functional alterations of macrophages in autoimmune MRL-lpr/lpr mice. J Immunol 138:1757-1761 (1987).
68. Spurney RF, Fan PY, Ruiz P, Sanfilippo F, Pisetsky DS, Coffman TM. Thromboxane receptor blockade reduces renal injury in murine lupus nephritis. Kidney Internat 41:973-982 (1992).
69. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946 (1995).
70. Cantin R, Fortin JF, Lamontagne G, Tremblay M, The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells. Blood 90:1091-1100 (1997).
71. Huang FP, Feng GJ, Lindop G, Stott DI, Liew FY. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL:MP-lpr/lpr mice. J Exp Med 183:1447-1459 (1996).
72. Oates JC, Ruiz P, Alexander A, Pippen AMM, Gilkeson GS. Effect of late modulation of nitric oxide production on murine lupus. Clin Immunol Immunopath 83:86-92 (1997).
73. Henty Y, Lepoivre M, Drapier JC, Ducrocq C, Boucher JL, Guissani A. EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J 7:1124-1134 (1993).
74. Weinberg JB, Gilkeson GS, Mason RP, Chamulitrat W. Nitrosylation of blood hemoglobin and renal nonheme proteins in autoimmune MRL-lpr/lpr mice. Free Radic Biol Med 24:191-196 (1998).
75. Beckman JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler 375:81-88 (1994).
76. Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respir Crit Care Med 151:1250-1254 (1995).
77. Haddad IY, Pataki G, Hu P, Galliani C, Beckman JS, Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest 94:2407-2413 (1994).
78. Privalle CT, Keng T, Gilkeson GS, Weinberg JB. The role of nitric oxide and peroxynitrite in the pathogenesis of spontaneous murine autoimmune disease. In: The Biology of Nitric Oxide (Stamler J, Gross SS, Moncada S, eds). London:Portland Press, 1996;20.
79. Venkatraman JT, Chandrasekar B, Kim JD, Fernandes G. Genotype effects on the antioxidant enzymes activity and mRNA expression in liver and kidney tissues of autoimmuneprone MRL/MpJ-lpr/lpr mice. Biochim Biophys Acta 1213:167-175 (1994).
80. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75:1273-1286 (1993).
81. Macmicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, Chen H, Mudgett JS. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650 (1995).
82. Laubach VE, Shesely EG, Smithies O, Sherman PA. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 92:10688-10692 (1995).
83. Wei XQ, Charles IG, Smith A, Ure J, Feng CJ, Huang FP, Xu DM, Muller W, Moncada S, Liew FY. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411 (1995).
84. Huang PL, Huang ZH, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377:239-242 (1995).
85. Macmicking JD, North RJ, Lacourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 94:5243-5248 (1997).
86. Gilkeson GS, Mudgett JS, Seldin MF, Ruiz P, Alexander AA, Misukonis MA, Pisetsky DS, Weinberg JB. Clinical and serologic manifestations of autoimmune disease In MRL-lpr/lpr mice lacking nitric oxide synthase type 2. J Exp Med 186:365-373 (1997).
87. Hang L, Theofilopoulos AN, Dixon FJ. A spontaneous rheumatoid arthritis-like disease in MRL-1 mice. J Exp Med 155:1690-1701 (1982).
88. Nose M, Nishimura M, Kyogoku M. Analysis of granulomatous arteritis in MRL/Mp autoimmune disease mice bearing lymphoproliferative genes. The use of mouse genetics to dissociate the development of arteritis and glomerulonephritis. Am J Pathol 135:271-280 (1989).
89. Tarkowski A, Jonsson R, Sanchez R, Klareskog L, Koopman WJ. Features of renal vasculitis in autoimmune MRL lpr/lpr mice: phenotypes and functional properties of infiltrating cells. Clin Exp Immunol 72:91-97 (1988).
90. Takahashi S, Nose M, Sasaki J, Yamamoto T, Kyogoku M. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis. J Immunol 147:515-519 (1991).
91. Genaro AM, Hortelano S, Alvarez A, Martineza C, Bosca L. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest 95:1884-1890 (1995).
92. Southan GJ, Szabo C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 51:383-394 (1996).